I am personally invested in the development of UNLTD Life Sciences, an early-stage research initiative that focuses on extending healthy human lifespan. Our mission is to pursue rigorous research into the biological aging process, with a clear goal of enhancing healthspan. By doing so, we aim to preserve crucial functions such as cognition, mobility, and organ integrity, while also exploring how these advances could contribute to a longer, healthier life.

Our scientific roadmap is rooted in realistic and responsible research. We prioritize established human evidence over speculative claims. Our work encompasses biological repair, tissue and organ regeneration, cellular rejuvenation, and neural preservation, leveraging the advances in computation and artificial intelligence.

The potential of our initiative is great, and so is the risk—research in longevity is challenging and demands high-impact, innovative approaches. However, the journey to discovering revolutionary healthspan technologies requires broader support and infrastructure to thrive. This is why we appeal to ARPA-H to expand their support for emerging and independent research initiatives like ours that are committed to advancing longevity science.

By supporting initiatives like UNLTD Life Sciences, ARPA-H would not only be facilitating groundbreaking discoveries but also investing in the future of public health and medicine. It's time to catalyze the development of new tools and technologies that not only extend life but enhance the quality of it for all.

Join us in urging ARPA-H to embrace this vision for a healthier future. Sign the petition to support groundbreaking research initiatives and help transform medical science in unprecedented ways. Together, we can make a lasting impact.